Tony Mok

机构：Chinese University of Hong Kong, Translational Research in Oncology, Prince of Wales Hospital

发表论文 1093 篇 · 总被引 108115 次 · h-index 130

代表论文

• Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches (2025 · Nature Reviews Clinical Oncology · 被引 33)
• Robotic-assisted and electromagnetic navigation bronchoscopy for multi-focal lung cancers: a narrative review (2025 · Translational Lung Cancer Research · 被引 4)
• A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America (2025 · Frontiers in Oncology · 被引 4)
• Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib (2025 · Lung Cancer · 被引 3)
• Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial (2026 · Nature Medicine · 被引 1)
• First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non–Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study (2026 · Clinical Cancer Research · 被引 1)